Statins and Hip Fracture Prevention – A Population Based Cohort Study in Women
Open Access
- 29 October 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (10) , e48095
Abstract
To study the association of long-term statin use and the risk of low-energy hip fractures in middle-aged and elderly women. A register-based cohort study. Finland. Women aged 45–75 years initiating statin therapy between 1996 and 2001 with adherence to statins ≥80% during the subsequent five years (n = 40 254), a respective cohort initiating hypertension drugs (n = 41 610), and women randomly selected from the population (n = 62 585). Incidence rate of and hazard ratio (HR) for low-energy hip fracture during the follow-up extending up to 7 years after the 5-year exposure period. Altogether 199 low-energy hip fractures occurred during the 135 330 person-years (py) of follow-up in the statin cohort, giving an incidence rate of 1.5 hip fractures per 1000 py. In the hypertension and the population cohorts, the rates were 2.0 per 1000 py (312 fractures per 157 090 py) and 1.0 per 1000 py (212 fractures per 216 329 py), respectively. Adjusting for a propensity score and individual variables strongly predicting the outcome, good adherence to statins for five years was associated with a 29% decreased risk (HR 0.71; 95% CI 0.58–0.86) of a low-energy hip fracture in comparison with adherent use of hypertension drugs. The association was of the same magnitude when comparing the statin users with the population cohort, the HR being 0.69 (0.55–0.87). When women with poor (<40%), moderate (40 to 80%), and good adherence (≥80%) to statins were compared to those with good adherence to hypertension drugs (≥80%) or to the population cohort, the protective effect associated with statin use attenuated with the decreasing level of adherence. 5-year exposure to statins is associated with a reduced risk of low-energy hip fracture in women aged 50–80 years without prior hospitalizations for fractures.Keywords
This publication has 43 references indexed in Scilit:
- A systematic review of hip fracture incidence and probability of fracture worldwideOsteoporosis International, 2012
- Evaluation of trabecular microarchitecture in nonosteoporotic postmenopausal women with and without fractureJournal of Bone and Mineral Research, 2012
- The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustrationPharmacoepidemiology and Drug Safety, 2011
- Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized ratsJournal of Bone and Mineral Metabolism, 2010
- Rosuvastatin Promotes Osteoblast Differentiation and Regulates SLCO1A1 Transporter Gene Expression in MC3T3-E1 CellsCellular Physiology and Biochemistry, 2010
- Statin Adherence and Risk of AccidentsCirculation, 2009
- Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized ratsEuropean Journal of Clinical Investigation, 2009
- Utilization of routinely collected administrative data in monitoring the incidence of aging dependent hip fractureEpidemiologic Perspectives & Innovations, 2007
- NNT for studies with long-term follow-upCanadian Medical Association Journal, 2005
- Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cellsJournal of Cellular Biochemistry, 2004